Location History:
- Seoul, KR (2001)
- New York, NY (US) (1998 - 2003)
Company Filing History:
Years Active: 1998-2003
Title: In Jong Kim: Innovator in Cancer Research
Introduction
In Jong Kim is a prominent inventor based in New York, NY (US), known for his significant contributions to cancer research. He holds a total of 4 patents, showcasing his innovative approaches in the field of oncology.
Latest Patents
One of his latest patents is focused on the synthesis of glycoconjugates of the globo-H epitope and their uses in colon cancer. This invention provides processes for the preparation of the KH-1 and N3 antigens, along with related analogues that are useful as anticancer therapeutics. The invention also details various intermediates useful in the preparation of KH-1 and N3 and their analogues. Additionally, it offers various compositions comprising any of the analogues of KH-1 and N3, which are available through the methods of the invention, along with pharmaceutical carriers useful in treating subjects suffering from various forms of epithelial cancer.
Career Highlights
In Jong Kim is affiliated with the Sloan Kettering Institute for Cancer Research, where he continues to advance his research and innovations in cancer therapeutics. His work has been instrumental in developing new strategies for cancer treatment.
Collaborations
He has collaborated with notable colleagues in the field, including Samuel J. Danishefsky and Philip O. Livingston, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
In Jong Kim's contributions to cancer research through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in cancer therapeutics.